•
Dec 31, 2017

Jazz Pharmaceuticals Q4 2017 Earnings Report

Total Revenue
$436M
Previous year: $397M
+10.0%
EPS
$2.95
Previous year: $2.71
+8.9%
Gross Profit
$411M
Previous year: $363M
+13.3%
Cash and Equivalents
$386M
Previous year: $366M
+5.5%
Total Assets
$5.12B
Previous year: $4.8B
+6.7%

Jazz Pharmaceuticals

Jazz Pharmaceuticals